arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2512.03471cs.LGcs.CY
收藏

SweetDeep:一种用于实时无创糖尿病筛查的可穿戴AI解决方案

SweetDeep: A Wearable AI Solution for Real-Time Non-Invasive Diabetes Screening

Department of Electrical and Computer Engineering, Princeton University(普林斯顿大学电气与计算机工程系);NeuTigers, Inc.(NeuTigers公司);AP-HP Avicennes, Bobigny, France(法国AP-HP阿维尼翁医院);Clinic International Constantine, Constantine, Algeria(阿尔及利亚康斯坦丁国际诊所)
Ian Henriques, Lynda Elhassar, Sarvesh Relekar, Denis Walrave, Shayan Hassantabar, Vishu Ghanakota, Adel Laoui, Mahmoud Aich, Rafia Tir, Mohamed Zerguine, Samir… 展开作者

Ian Henriques, Lynda Elhassar, Sarvesh Relekar, Denis Walrave, Shayan Hassantabar, Vishu Ghanakota, Adel Laoui, Mahmoud Aich, Rafia Tir, Mohamed Zerguine, Samir Louafi, Moncef Kimouche, Emmanuel Cosson, Niraj K Jha

AI总结:

SweetDeep利用轻量级神经网络和工程特征,在真实可穿戴设备上实现了高准确率的2型糖尿病无创筛查。

摘要:

全球2型糖尿病的上升趋势凸显了需要可扩展且成本效益高的筛查方法。目前的诊断需要生化检测,这具有侵入性和成本。消费者可穿戴设备的进步使早期探索基于机器学习的疾病检测成为可能,但先前研究仅限于受控环境。我们提出了SweetDeep,这是一个紧凑的神经网络,训练于来自欧盟和中东和北非地区285名(糖尿病和非糖尿病)参与者在六天内通过三星Galaxy Watch 7设备收集的生理和人口统计数据,这些数据是在自由生活条件下收集的。每位参与者每天贡献多个2分钟传感器记录,总计约20次记录。尽管参数少于3000个,SweetDeep在三折交叉验证下实现了82.5%的患者级准确率(82.1%宏F1,79.7%灵敏度,84.6%特异性),预期校准误差为5.5%。允许模型在低于10%的低置信度患者预测中放弃,可使剩余患者的准确率提高至84.5%。这些发现表明,结合工程特征与轻量级架构可以支持在真实可穿戴环境中快速、准确和可推广的2型糖尿病检测。

英文摘要:

The global rise in type 2 diabetes underscores the need for scalable and cost-effective screening methods. Current diagnosis requires biochemical assays, which are invasive and costly. Advances in consumer wearables have enabled early explorations of machine learning-based disease detection, but prior studies were limited to controlled settings. We present SweetDeep, a compact neural network trained on physiological and demographic data from 285 (diabetic and non-diabetic) participants in the EU and MENA regions, collected using Samsung Galaxy Watch 7 devices in free-living conditions over six days. Each participant contributed multiple 2-minute sensor recordings per day, totaling approximately 20 recordings per individual. Despite comprising fewer than 3,000 parameters, SweetDeep achieves 82.5% patient-level accuracy (82.1% macro-F1, 79.7% sensitivity, 84.6% specificity) under three-fold cross-validation, with an expected calibration error of 5.5%. Allowing the model to abstain on less than 10% of low-confidence patient predictions yields an accuracy of 84.5% on the remaining patients. These findings demonstrate that combining engineered features with lightweight architectures can support accurate, rapid, and generalizable detection of type 2 diabetes in real-world wearable settings.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑